These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 480619)

  • 41. Effects of vitamin D metabolites and analogues on renal function.
    Naik RB; Cundy T; Robinson BH; Russell RG; Kanis JA
    Nephron; 1981; 28(1):17-25. PubMed ID: 6894966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
    Phillips ME; Havard J; Otterud B
    Am J Clin Nutr; 1980 Jul; 33(7):1541-5. PubMed ID: 6893104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of calcium-phosphate metabolism disorders in renal diseases].
    Manitius A; Rutkowski B
    Pol Arch Med Wewn; 1977 Nov; 58(5):509-14. PubMed ID: 341094
    [No Abstract]   [Full Text] [Related]  

  • 44. Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3.
    Marx SJ; Swart EG; Hamstra AJ; DeLuca HF
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1138-42. PubMed ID: 6893458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].
    Schulz W; Spiegel P; Gessler U; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1297-301. PubMed ID: 741953
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets.
    Kraft D; Offermann G; Steldinger R; Gawlik D
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developmental changes in the responsiveness of rat kidney to vitamin D metabolites.
    Sömjen D; Weisman Y; Berger E; Earon Y; Kaye AM; Binderman I
    Endocrinology; 1986 Jan; 118(1):354-9. PubMed ID: 3000745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does uremic bone disease warrant early treatment with calcitriol?
    Chesney RW
    Arch Intern Med; 1980 Aug; 140(8):1016-7. PubMed ID: 6893117
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intestinal calcium absorption in the early stage of renal insufficiency and the effect of 5,6-trans-25-OHCC].
    Werner E; Malluche HH; Ritz E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1305-7. PubMed ID: 611840
    [No Abstract]   [Full Text] [Related]  

  • 51. Demonstration of a 1,25-dihydroxycholecalciferol cytoplasmic receptor-like binder in mouse kidney.
    Colston KW; Feldman D
    J Clin Endocrinol Metab; 1979 Nov; 49(5):798-800. PubMed ID: 489720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract]   [Full Text] [Related]  

  • 53. Modulation of renal production of 24,25- and 1,25-dihydroxyvitamin D3 in young and adult rats by dietary calcium, phosphorus, and 1,25-dihydroxyvitamin D3.
    Armbrecht HJ; Zenser TV; Davis BB
    Endocrinology; 1982 Jun; 110(6):1983-8. PubMed ID: 6978809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1alpha-hydroxycholecalciferol and renal function.
    Lund B; Sørensen OH; Lund B
    Lancet; 1978 Sep; 2(8092 Pt 1):731. PubMed ID: 80649
    [No Abstract]   [Full Text] [Related]  

  • 55. [1-alpha-hydroxycholecalciferol. Treatment of patients with chronic renal insufficiency requiring dialysi].
    Krolner B; Schaadt O; Christensen MS; Clausen E; Lund B; Melsen F; Nielsen SP; Sorensen OH
    Ugeskr Laeger; 1977 Apr; 139(15):880-4. PubMed ID: 847827
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative study of the effects of alpha-25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol on calcium-phosphorus metabolism and on bone tissue in experimental kidney insufficiency in rats].
    Alekseeva AI; Spirichev VB; Bogoslovskiĭ NA; Kisel'nikova TA
    Vopr Med Khim; 1983; 29(5):103-12. PubMed ID: 6606264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcitroic acid: biological activity and tissue distribution studies.
    Esvelt RP; De Luca HF
    Arch Biochem Biophys; 1981 Feb; 206(2):403-13. PubMed ID: 6261697
    [No Abstract]   [Full Text] [Related]  

  • 58. Intestinal calcium-binding protein (CaBP) and bone calcium mobilization in response to 1,24(R),25-(OH)3D3. Comparative effects of 1,25-(OH)2D3 and 24(R),25-(OH)2D3 in rats.
    Thomasset M; Cuisinier-Gleizes P; Mathieu H; DeLuca HF
    Mol Pharmacol; 1980 May; 17(3):362-6. PubMed ID: 6967147
    [No Abstract]   [Full Text] [Related]  

  • 59. The kidney as an endocrine organ involved in the function of vitamin D.
    DeLuca HF
    Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A 1,25 dihydroxyvitamine D-like substance as the cause of calcinogenic effect of yellow oats (Trisetum flavescens)].
    Peterlik M; Regal DS; Köhler H
    Dtsch Tierarztl Wochenschr; 1977 Jul; 84(7):253-5. PubMed ID: 330134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.